Leaflet: information for the user
Bisoprolol Teva-ratiopharm 2.5mg tablets EFG
bisoprolol fumarate
Read this leaflet carefully before you start to take this medicine, because it contains important information for you.
|
Bisoprolol Teva-ratiopharm contains the active ingredient bisoprolol fumarate. Bisoprolol belongs to a group of medicines called beta-blockers. Bisoprolol prevents irregular heartbeats (arrhythmia) during stress and reduces the cardiovascular workload. Bisoprolol also dilates blood vessels and therefore facilitates blood flow.
Bisoprolol is used for:
Do not take Bisoprolol Teva-ratiopharm
Warnings and precautions
Inform your doctor or pharmacist before taking this medication, they may want to take special precautions (e.g., provide additional treatment or perform more frequent examinations):
If you have a chronic lung disease or mild asthma, please inform your doctor immediately if you begin to experience new breathing difficulties, cough, whistling after exercise, etc., while using bisoprolol.
Children and adolescents
Bisoprolol is not recommended for use in children or adolescents.
Other medications and Bisoprolol Teva-ratiopharm
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
Do not take the following medications with Bisoprolol Teva-ratiopharm without special advice from your doctor:
However,do not stop taking these medicationswithout consulting your doctor first.
Consult with your doctor before taking the following medications with Bisoprolol Teva-ratiopharm; your doctor may need to monitor your condition more frequently:
Pregnancy and lactation
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before using this medication.
Bisoprolol should not be used during pregnancy unless clearly necessary. If you are pregnant or plan to become pregnant during treatment with Bisoprolol Teva-ratiopharm, inform your doctor for advice on an appropriate treatment.
The excretion of bisoprolol in breast milk is unknown. Therefore, breastfeeding is not recommended during the use of this medication.
Bisoprolol has a minimal or no impact on the ability to drive. Adverse effects related to low blood pressure may include dizziness, headache, fatigue, or other adverse effects (see section 4) that may impair the ability to drive or operate machinery. If you experience these adverse effects, do not drive vehicles and/or operate machinery that require your full attention. In particular, attention is required at the start of treatment and after increasing the dose. Bisoprolol normally does not affect the ability to drive if the treatment is well balanced.
Bisoprolol Teva-ratiopharm contains sodium
This medication contains less than 23 mg of sodium (1 mmol) per tablet; it is essentially "sodium-free".
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist.
The treatment with bisoprolol requires regular monitoring by your doctor. This is particularly necessary at the beginning of treatment, during dose increase, and at the end of treatment.
The treatment with bisoprolol is usually long-term.
The recommended dose is
Adults:
For treating hypertension and angina pectoris
For treating chronic stable heart failure
Treatment with bisoprolol should be initiated at a low dose and increased gradually. Your doctor will decide how to increase the dose, and this will be done normally as follows:
The maximum recommended daily dose is 10 mg of bisoprolol.
Depending on how well you tolerate the medication, your doctor may decide to also prolong the time between dose increases. If your condition worsens or you no longer tolerate the medication, it may be necessary to reduce the dose again or discontinue treatment. In some patients, a maintenance dose less than 10 mg of bisoprolol may be sufficient. Your doctor will tell you what to do. Normally, if you have to discontinue treatment completely, your doctor will advise you to reduce the dose gradually, as otherwise your condition may worsen.
Use in children and adolescents (under 18 years)
There is not enough experience with the use of bisoprolol in children, and therefore bisoprolol is not recommended for use in children or adolescents under 18 years.
Older patients
No dose adjustment is necessary in the elderly unless you have renal or hepatic insufficiency, see below.
Patients with renal or hepatic insufficiency
The dose must be increased gradually and with caution in patients with severe hepatic or renal problems. The dose should not exceed 10 mg once a day in patients with severe renal or hepatic problems.
Normally, no dose adjustment is required in patients with mild to moderate renal or hepatic insufficiency.
Administration form
Swallow the tablets with sufficient liquid (e.g., a glass of water) usually once a day in the morning. The tablets should not be chewed. Food does not affect the absorption of the medication.
If you take more Bisoprolol Teva-ratiopharm than you should
If you have taken an overdose of Bisoprolol Teva-ratiopharm, consult your doctor or a hospital immediately.
The symptoms of an overdose may include a reduced heart rate, severe difficulty breathing, feeling of dizziness, or tremors (due to decreased blood sugar).
In case of overdose or accidental ingestion, consult the Toxicology Information Service. Telephone 91562 04 20, indicating the medication and the amount taken. It is recommended to bring the packaging and the medication leaflet to the healthcare professional.
If you forgot to take Bisoprolol Teva-ratiopharm
Take the next tablet normally when it is time to take it. Do not take a double dose to compensate for the missed doses.
If you discontinue treatment with Bisoprolol Teva-ratiopharm
Treatment with bisoprolol should not be discontinued abruptly, particularly when the patient has heart disease. The dose should be reduced gradually, for example over 1-2 weeks. Otherwise, the symptoms of heart disease may worsen.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine may cause side effects, although not everyone will experience them.
To prevent serious adverse reactions, talk to your doctor immediately if a side effect is severe, occurs suddenly, or worsens quickly.
The most serious side effects are related to heart function:
If you feel dizzy or weak, or have difficulty breathing, contact your doctor as soon as possible.
Below are other side effects listed according to their frequency of possible occurrence:
Frequent(may affect up to 1 in 10 people)
Infrequent(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Very rare(may affect up to 1 in 10,000 people):
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a side effect that does not appear in this prospectus. You can also report them directly through theSpanish System for the Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es.By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the blister pack and on the packaging after CAD. The expiration date refers to the last day of the month indicated.
This medication does not require special conditions for conservation.
Medications should not be disposed of through drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medications. By doing so, you will help protect the environment.
Composition of Bisoprolol Teva-ratiopharm
The active ingredient is bisoprolol fumarate.
Each tablet contains 2.5 mg of bisoprolol fumarate.
The other components are: microcrystalline cellulose (E 460), anhydrous colloidal silica, sodium croscarmellose, sodium carboxymethylamidone type IA (from potato) and magnesium stearate (E 572).
Appearance of the product and contents of the packaging
Bisoprolol Teva-ratiopharm 2.5 mg tablets are white to off-white, round, biconvex tablets with a notch on one face.
The packaging includes 28 tablets.
Teva Pharma, S.L.U
C/ Anabel Segura 11, Edificio Albatros B, 1st floor
28108 Alcobendas. Madrid
Chanelle Medical
Dublin Road, Loughrea, Co. Galway
Irlanda
or
Merckle GmbH
Ludwig-Merckle-Strasse 3
89143 Blaubeuren
Germany
This medicine is authorized in the Member States of the European Economic Area with the following names:
Spain: Bisoprolol Teva-ratiopharm 2.5 mg tablets EFG
Last review date of this leaflet: August 2022
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
You can access detailed and updated information on this medicine by scanning the QR code included in the carton with your smartphone. You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/83408/P_83408.html
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.